Monitor upcoming proxy filings for any disclosure of new board appointments or changes in governance structure. Absent unexpected leadership shifts, this event is routine and unlikely to impact trading dynamics.
APGE drugs
APGE drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $86.47entry
- T+1 · 7mo ago −1.27%α −0.79% · $85.37
- T+5 · 7mo ago −3.38%α −3.78% · $83.55
- T+20 · 6mo ago −4.23%α −9.19% · $82.81
- T+60 · 4mo ago +55.06%α +50.28% · $134.08
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Apogee Therapeutics announced the resignation of two board members, Andrew Gottesdiener, M.D. and Peter Harwin, effective May 11, 2026. The departures are not due to disagreements with the company, and the board will be reduced from nine to seven members.
Key Facts
- Andrew Gottesdiener, M.D. and Peter Harwin resigned from the board effective May 11, 2026
- Resignations were not due to disagreements with the company
- Board size reduced from nine to seven directors
- No immediate replacements named
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential governance instability if key board committees lose members
- Market perception risk if no replacements are named in a timely manner
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-177288 |
| Document: 0001193125-26-177288-index-headers.html | 0001193125-26-177288 |
| Document: 0001193125-26-177288-index.html | 0001193125-26-177288 |
| Document: 0001193125-26-177288.txt | 0001193125-26-177288 |
Track record
31 reports on APGE
9 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +73.31% at T+60 after the May 27, 2026 report. 12 of 13 went positive at some point.
Filters
- Sep 14, 20269w ago 15-12G Neutral 4/10 No price data
- Sep 3, 202610w ago 25-NSE Bullish 8/10 Entry $135.06 No price data
- Sep 3, 202610w ago 8-K Bullish 8/10 Entry $135.06 No price data
- Aug 11, 202613w ago 8-K Bullish 7/10 Entry $134.55 No price data
- Aug 10, 202614w ago 8-K Bullish 8/10 No price data
- Aug 10, 202614w ago Press Release Bullish 8/10 Entry $134.65 No price data
- Aug 6, 202614w ago Institutional Cluster Mixed 5/10 Entry $134.49 to $135.07 ▲ +0.43% −0.17% vs SPY
- Aug 3, 202615w ago DEFA14A Bullish 5/10 Entry $134.19 to $135.08 ▲ +0.66% +1.90% vs SPY
- Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $133.82 to $134.65 ▲ +0.62% −2.56% vs SPY
- Jun 26, 202620w ago DEFA14A Bullish 6/10 Entry $132.61 to $134.28 ▲ +1.26% +1.54% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers